EUVIMEDDécouvrir EUVIMED
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen access · CC BY 4.0

Detection and treatment of peritoneal metastases in colon cancer: COLOPEC trial compared to routine practice

Iris Hochstenbach iD, Julie J M Hamm iD, Eva Rademaker iD, Arend G J Aalbers, Djamila Boerma, Wilhelmina M U van Grevenstein, Patrick H J Hemmer iD, Ignace H J T De Hingh, Niels F M Kok iD, Jurriaan B Tuynman, Eva V E Madsen iD, Johannes H W de Wilt iD and 4 more

Colorectal Disease · 2026

DOI: 10.1111/codi.70614 ↗

At a glance

Vergleichsstudie in Colorectal Disease, 2026. Written by Iris Hochstenbach and 15 co-authors. Institution: Department of Surgery, Isala, Zwolle, the Netherlands. Major MEDLINE topics: Peritoneal Neoplasms, Colonic Neoplasms, Hyperthermic Intraperitoneal Chemotherapy. 24 references. The full text is freely available (open access, CC BY 4.0). Funded by: KWF Kankerbestrijding, ZonMw, Isala Academy for Innovation and research.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Aim

The randomized COLOPEC trial demonstrated no benefit of adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in preventing peritoneal metastases in locally advanced colon cancer. Because all patients underwent a diagnostic laparoscopy at 18 months, the study lacked a true control arm, leaving the effect of early detection and treatment compared with standard care uncertain. This study aimed to compare long‐term oncological outcomes between patients treated in the COLOPEC trial and patients treated in routine care.

Method

Patients who underwent curative resection for c/pT4 or perforated colon cancer in the COLOPEC trial were compared with a retrospective control cohort that included all colon cancer resections performed in 2014–2015, in 50 Dutch hospitals. All 202 trial patients were matched 1:1 to 202 control patients using propensity score matching.

Results

Following treatment in both arms of the COLOPEC trial, compared to the matched control cohort, 5‐year overall survival was 70.2% versus 72.8% ( p = 0.77). Five‐year disease‐free survival was 62.1% versus 65.2% ( p = 0.31) and five‐year cumulative incidence of peritoneal metastases was 24.4% Versus 9.5% ( p < 0.001). Cytoreductive surgery with HIPEC for peritoneal recurrence was performed in 28 (13.9%) versus 7 patients (3.5%; p < 0.001).

Conclusion

Despite increased detection and more frequent treatment of peritoneal metastases in the COLOPEC trial, 5‐year overall and disease‐free survival were comparable to routine practice.

Subjects

MeSH terms (MEDLINE)

Peritoneal NeoplasmsColonic NeoplasmsHyperthermic Intraperitoneal ChemotherapyHumansFemaleMaleRetrospective StudiesMiddle AgedAgedDisease-Free SurvivalTreatment OutcomeChemotherapy, AdjuvantPropensity ScoreNetherlandsLaparoscopyColorectal Surgical ProceduresHyperthermia, Induced

Author keywords

adjuvant hyperthermic intraperitoneal chemotherapycolon cancerlocally advanced colon cancerperitoneal metastasespropensity score matchingroutine practicesecond‐look surgery

Authors and institutions

  • Department of Surgery, Isala, Zwolle, the Netherlands.
  • Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands.
  • Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Department of Surgery, Antoni van Leeuwenhoek Hospital/the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Department of Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands.

ORCID profiles: Iris Hochstenbach, Julie J M Hamm, Eva Rademaker, Patrick H J Hemmer, Niels F M Kok, Eva V E Madsen, Johannes H W de Wilt, Esther C J Consten, Pieter J Tanis

Funding

  • KWF Kankerbestrijding
  • ZonMw
  • Isala Academy for Innovation and research

Cite

APA

Hochstenbach, I., Hamm, J. J. M., Rademaker, E., Aalbers, A. G. J., Boerma, D., van Grevenstein, W. M. U., Hemmer, P. H. J., De Hingh, I. H. J. T., Kok, N. F. M., Tuynman, J. B., Madsen, E. V. E., de Wilt, J. H. W., Consten, E. C. J., van Westreenen, H. L., Tanis, P. J., & COLOPEC Collaborators Group, Dutch Snapshot Research Group and Dutch Complex Colon Cancer Initiative (2026). Detection and treatment of peritoneal metastases in colon cancer: COLOPEC trial compared to routine practice. Colorectal Disease. https://doi.org/10.1111/codi.70614

Vancouver

Hochstenbach I, Hamm JJM, Rademaker E, Aalbers AGJ, Boerma D, van Grevenstein WMU, et al. Detection and treatment of peritoneal metastases in colon cancer: COLOPEC trial compared to routine practice. Colorectal Disease. 2026. doi:10.1111/codi.70614

BibTeX
@article{Hochstenbach2026,
  author = {Hochstenbach, Iris and Hamm, Julie J M and Rademaker, Eva and Aalbers, Arend G J and Boerma, Djamila and van Grevenstein, Wilhelmina M U and Hemmer, Patrick H J and De Hingh, Ignace H J T and Kok, Niels F M and Tuynman, Jurriaan B and Madsen, Eva V E and de Wilt, Johannes H W and Consten, Esther C J and van Westreenen, Henderik L and Tanis, Pieter J and COLOPEC Collaborators Group, Dutch Snapshot Research Group and Dutch Complex Colon Cancer Initiative, COLOPEC Collaborators Group, Dutch Snapshot Research Group and Dutch Complex Colon Cancer Initiative},
  title = {Detection and treatment of peritoneal metastases in colon cancer: COLOPEC trial compared to routine practice},
  journal = {Colorectal Disease},
  year = {2026},
  doi = {10.1111/codi.70614}
}
Start for free →